Total de visites
| Visites | |
|---|---|
| CEMCAT ... | 254 |
Total de visites per mes
| d’octubre 2023 | de novembre 2023 | de desembre 2023 | de gener 2024 | de febrer 2024 | de març 2024 | d’abril 2024 | |
|---|---|---|---|---|---|---|---|
| CEMCAT ... | 4 | 6 | 4 | 9 | 8 | 5 | 14 |
Visites per país
| Visites | |
|---|---|
| Espanya | 121 |
| Estats Units | 43 |
| Irlanda | 11 |
| Xina | 10 |
| Suècia | 10 |
| Costa d'Ivori | 5 |
| França | 4 |
| Corea del Sud | 4 |
| Regne Unit | 3 |
| Japó | 3 |
Visites per ciutat
| Visites | |
|---|---|
| Barcelona | 65 |
| Chandler | 12 |
| Dublin | 11 |
| Capellades | 10 |
| Sant Feliu de Llobregat | 5 |
| Ashburn | 4 |
| Busan | 4 |
| Daloa | 4 |
| Shanghai | 4 |
| Badalona | 3 |
Documents més visitats
| Visites | |
|---|---|
| Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results | 491 |
| Traffic Lights Intervention Reduces Therapeutic Inertia: A Randomized Controlled Trial in Multiple Sclerosis Care | 295 |
| Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome | 286 |
| Adherence and satisfaction of smartphone- and smartwatch-based remote active testing and passive monitoring in people with multiple sclerosis: nonrandomized interventional feasibility study | 243 |
| Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis: a longitudinal OCT study | 225 |
| Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health Solutions | 108 |
| The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction | 100 |
| Increased NLRP3 Inflammasome Activation and Pyroptosis in Patients With Multiple Sclerosis With Fingolimod Treatment Failure | 99 |
| Immunosenescence in multiple sclerosis: the identification of new therapeutic targets | 95 |
| Cognitive assessment in patients with multiple sclerosis: A Spanish consensus | 89 |